✦ LIBER ✦

Benefit-Risk Assessment of Linezolid for Serious Gram-Positive Bacterial Infections

✍ Scribed by Dr Matthew E. Falagas, Konstantinos Z. Vardakas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antibiotics for gram-positive bacterial

✍ Lundstrom, Tammy S; Sobel, Jack D 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 262 KB

PIN24: COST EFFECTIVENESS ANALYSIS OF LI

✍ JZ Li; RJ Willke; DA Balan; D Nathwani; H López; BE Rittenhouse; M Tavacoli; E M 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Novel antibacterial agents for the treat

✍ Abbanat, Darren; Macielag, Mark; Bush, Karen 📂 Article 📅 2003 🏛 Informa plc 🌐 English ⚖ 308 KB

Linezolid (ZYVOX), the First Member of a

✍ Brickner, Steven J.; Barbachyn, Michael R.; Hutchinson, Douglas K.; Manninen, Pe 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 171 KB

Teicoplanin: A New Agent for Gram-Positi

✍ Mark Eggleston and Joseph Ofosu 📂 Article 📅 1988 🏛 University of Chicago Press 🌐 English ⚖ 589 KB

Linezolid for the treatment of infection

✍ Dong-fang Lin; Ying-yuan Zhang; Ju-fang Wu; Fu Wang; Jing-chuan Zheng; Jing-zhi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 131 KB